ALS RESEARCH AMBASSADOR Trademark

Trademark Overview

On Friday, January 17, 2020, a trademark application was filed for ALS RESEARCH AMBASSADOR with the United States Patent and Trademark Office. The USPTO has given the ALS RESEARCH AMBASSADOR trademark a serial number of 88763715. The federal status of this trademark filing is REGISTERED as of Tuesday, February 16, 2021. This trademark is owned by Northeast Amyotrophic Lateral Sclerosis Consortium. The ALS RESEARCH AMBASSADOR trademark is filed in the category with the following description:

advocacy services, namely, promoting and advancing public awareness of and support for clinical research and treatments to benefit people with Amyotrophic Lateral Sclerosis (ALS) and/or motor neuron disease
als research ambassador

General Information

Serial Number88763715
Word MarkALS RESEARCH AMBASSADOR
Filing DateFriday, January 17, 2020
Status700 - REGISTERED
Status DateTuesday, February 16, 2021
Registration Number6274499
Registration DateTuesday, February 16, 2021
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and Servicesadvocacy services, namely, promoting and advancing public awareness of and support for clinical research and treatments to benefit people with Amyotrophic Lateral Sclerosis (ALS) and/or motor neuron disease
Pseudo MarkAMYOTROPHIC LATERAL SCLEROSIS RESEARCH AMBASSADOR
Certification Mark StatementThe certification mark, as used by persons authorized by the certifier, is used to certify that each individual certified to use the mark has attended and satisfactorily completed a program conducted by the Northeast Amyotrophic Lateral Sclerosis Consortium, which program is dedicated to educating attendees on clinical research and therapy development and empowering this group to be advocates for Amyotrophic Lateral Sclerosis (ALS)-related clinical research.

Classification Information

International ClassB -
US Class CodesB
Class Status Code6 - Active
Class Status DateThursday, January 23, 2020
Primary CodeB
First Use Anywhere DateSunday, January 1, 2012
First Use In Commerce DateSunday, January 1, 2012

Trademark Owner History

Party NameNortheast Amyotrophic Lateral Sclerosis Consortium
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressPasadena, CA 911051955
Party NameNortheast Amyotrophic Lateral Sclerosis Consortium
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressPasadena, CA 911051955

Trademark Events

Event DateEvent Description
Tuesday, January 21, 2020NEW APPLICATION ENTERED
Monday, April 6, 2020ASSIGNED TO EXAMINER
Thursday, May 21, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, May 29, 2020ASSIGNED TO LIE
Thursday, January 23, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, April 10, 2020NON-FINAL ACTION WRITTEN
Friday, April 10, 2020NON-FINAL ACTION E-MAILED
Friday, April 10, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, May 29, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, May 29, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, June 9, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, June 23, 2020WITHDRAWN FROM PUB - OG REVIEW QUERY
Thursday, July 2, 2020PREVIOUS ALLOWANCE COUNT WITHDRAWN
Wednesday, July 8, 2020NON-FINAL ACTION WRITTEN
Wednesday, July 8, 2020NON-FINAL ACTION E-MAILED
Wednesday, July 8, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, July 20, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, July 23, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, July 23, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, September 18, 2020TEAS REQUEST FOR RECONSIDERATION RECEIVED
Thursday, September 24, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, September 24, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, November 6, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, September 11, 2020FINAL REFUSAL WRITTEN
Friday, September 11, 2020FINAL REFUSAL E-MAILED
Friday, September 11, 2020NOTIFICATION OF FINAL REFUSAL EMAILED
Friday, November 6, 2020NON-FINAL ACTION WRITTEN
Friday, November 6, 2020NON-FINAL ACTION E-MAILED
Tuesday, December 8, 2020NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Tuesday, November 24, 2020USE AMENDMENT FILED
Tuesday, November 24, 2020TEAS AMENDMENT OF USE RECEIVED
Tuesday, December 1, 2020AMENDMENT TO USE PROCESSING COMPLETE
Saturday, December 5, 2020USE AMENDMENT ACCEPTED
Saturday, December 5, 2020ATTORNEY REVIEW COMPLETED
Tuesday, December 15, 2020EXAMINER'S AMENDMENT ENTERED
Tuesday, December 15, 2020EXAMINERS AMENDMENT -WRITTEN
Tuesday, December 15, 2020EXAMINERS AMENDMENT E-MAILED
Tuesday, December 15, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, January 4, 2021ASSIGNED TO LIE
Wednesday, January 13, 2021LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, December 31, 2020APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Tuesday, February 16, 2021REGISTERED-SUPPLEMENTAL REGISTER
Thursday, October 7, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, October 7, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, December 3, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, December 3, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, December 3, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, September 3, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, September 3, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, September 3, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, October 7, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Related Keywords

ambassador research amyotrophic people benefit lateral sclerosis disease neuron motor treatments